Lichen International LtdLICN
Price$1.03Intrinsic value$1.5753% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $24.5M-40.9% YoYTTM through 31 Dec 2025
Net Income -$22MTTM through 31 Dec 2025
Free Cash Flow -$17.8MTTM through 31 Dec 2025

Margins

Current
Gross Margin37.3%
EBITDA Margin-57.3%
Operating Margin-73.7%
Net Margin-89.6%

Returns

-30.9%ROE
-28.8%ROA

Balance Sheet Health

Debt / Equity0.01x
Current Ratio7.73x
Net Debt-$26.4Mnet cash position
Cash & Equivalents$26.9M

Quality Metrics

Altman Z-Score2.45
Piotroski F-Score1 / 9
FCF Margin-72.8%

Multi-Year Trend

Revenue
'20'21'22'23'24'25
FY2025: $809K
Diluted EPS-$4.11TTM
'20'21'22'23'24'25
FY2025: $-4.14

Dividend

No dividend

Capital Allocation

Capex Intensity0.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.